2024 HCPCS Code J9371
Injection, vincristine sulfate liposome, 1 mg
TAGS: vincristine sulfate
Notice | HCPCS J9371 terminated on June 30, 2024. |
Short Description | Inj, vincristine sul lip 1mg |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | D - Discontinue procedure or modifier code |
HCPCS Action Effective Date | July 01, 2024 |
HCPCS Code Added Date | January 01, 2014 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J1561 - Gamunex-c/gammaked
- J1562 - Vivaglobin, inj
- J1566 - Immune globulin, powder
- J1568 - Octagam injection
- J1569 - Gammagard liquid injection
- J1570 - Ganciclovir sodium injection
- J1571 - Hepagam b im injection
- J1572 - Flebogamma injection
- J1573 - Hepagam b intravenous, inj
- J1574 - Inj, ganciclovir (exela)
- J1575 - Hyqvia 100mg immuneglobulin
- J1576 - Inj, panzyga, 500 mg
- J1580 - Garamycin gentamicin inj
- J1590 - Gatifloxacin injection
- J1595 - Injection glatiramer acetate
- J1596 - Inj, glycopyrrolate, 0.1 mg
- J1597 - Inj glycopyrrolate, glyrx-pf
- J1598 - Inj glycopyrrolate fres kabi
- J1599 - Ivig non-lyophilized, nos
- J1600 - Gold sodium thiomaleate inj